Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (296)
- COVID-19 (160)
- Compliance and enforcement (106)
- Safety monitoring and information (100)
- Legislation (81)
- Vaping hub (59)
- Manufacturing (58)
- Import and export (42)
- Labelling and packaging (41)
- Medicinal cannabis hub (29)
- Scheduling (national classification system) (24)
- Sunscreens (20)
- Weight loss products (18)
- Peptide products (11)
- Shortages and supply disruptions (10)
- Committees and advisory bodies (8)
- Cosmetics (6)
- Clinical trials (5)
- Unique Device Identification (UDI) hub (5)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1213 result(s) found, displaying 676 to 700
-
Safety updatesMedical device safety update regarding pulse oximeters limitations, including the effect of skin pigmentation.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesOn 4 January 2022 the TGA granted a further provisional determination to AstraZeneca Pty Ltd in relation to the COVID-19 treatment tixagevimab and cilgavimab (EVUSHELD).
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued three infringement notices, totalling $7,992, to an individual from South Australia for allegedly advertising medicinal cannabis in breach of the Therapeutic Goods Act 1989.
-
Regulatory decision noticesThe TGA granted provisional determination to Vaxine Pty Ltd in relation to their COVID-19 vaccine, Recombinant CoV-2-S-ΔTM protein with Advax-CpG55.2.
-
Media releasesThe TGA has issued three infringement notices totalling $39,960 for alleged unlawful advertising of medicinal cannabis in breach of the Therapeutic Goods Act 1989.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesTGA has tested a number of imported products labelled as ivermectin and found that they are counterfeit
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesAn overview of the regulation of personal protective equipment (PPE) in Australia, including face masks, gowns and gloves
-
Media releasesThe TGA has provisionally approved a booster dose of the Moderna COVID-19 vaccine, SPIKEVAX, for individuals 18 years and older.
-
Media releasesDangerous and prohibited ingredients were found in two out of every three nicotine vaping products tested by the TGA, following a joint operation conducted by ACT Health and the TGA in response to community tip-offs.
-
Media releasesNew trial (beta) tool to search the Australian Register of Therapeutic Goods (ARTG) available.
-
Media releasesTGA grants provisional approval to Celltrion Healthcare Australia Pty Ltd for COVID-19 treatment, regdanvimab (REGKIRONA)
-
News articlesOn 6 December 2021, the TGA granted provisional approval to Celltrion Healthcare Australia Pty Ltd for the use of regdanvimab (REGKIRONA).
-
Pfizer's COVID-19 vaccine (COMIRNATY) provisionally approved for use in individuals 5 years and over
Media releasesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use in individuals 5 years and older. -
Media releasesA new Therapeutic Goods Advertising Code has been made commencing 1 January 2022, with transition period
-
Media releasesOutcomes of the court action against Oxymed Australia Pty Ltd
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued eight infringement notices totalling $106,560 to KL4 Pty Ltd (trading as Medcure), for the alleged importation of Ayurvedic medicines in breach of the Therapeutic Goods Act 1989